BiomarkersHumans
A comparison of four fully automated platforms for the measurement of plasma p ‐tau217 in the Alzheimer’s disease continuum
AAIC 2025 Abstract
Abstract
Background: Plasma p ‐tau217 outperforms other blood biomarkers for detecting Alzheimer’s disease (AD) pathology.
The paper
Marisa N. Denkinger, Sterling C. Johnson, Alpana Singh, Nicholas James Ashton
Show 23 more authors
James Liu, Kari Dieckhoff, Tainá M. Marques, Rachael E. Wilson, Ramiro Eduardo Rea Reyes, Antoine Leuzy, Valentina Ghisays, Elizabeth Head, Thomas G. Beach, Geidy E. Serrano, Alireza Atri, Maria-Magdalena Patru, Corey M. Carlson, Kinal Paresh Bhatt, Zivjena Vucetic, Arejas James Uzgiris, Eddine Merabet, Robert C. Alexander, Reisa Anne Sperling, Keith A. Johnson, Paul S. Aisen, Eric M. Reiman, Jessica B. S. Langbaum,Banner Sun Health Research Institute
AAIC 2025 Abstract · 23 Dec 2025 · CC BY
Presented at AAIC 2025
